Skip to main content
Log in

Dose dependent pharmacokinetics of prednisolone

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The pharmacokinetics of prednisolone elimination have been studied in both arthritic patients and normal volunteers using tritiated prednisolone alone, and in conjunction with unlabelled prednisolone in doses of 0.15 mg·kg−1 and 0.3 mg·kg−1 body weight. With increasing dose there is prolongation of the plasma half-life and increase in the volume of distribution and plasma clearance of prednisolone. It is proposed that these changes in pharmacokinetic parameters may be associated with non-linear binding of the steroid to plasma proteins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Coffey, J.J., Bullock, F.J., Schoenemann, P.T.: Numerical solution of non-linear pharmacokinetic equations: Effects of plasma protein binding on drug distribution and elimination. J. Pharm. Sci.60, 1623–1628 (1971)

    Google Scholar 

  2. Colburn, W.A., Buller, R.H.: Radioimmunoassay for prednisolone. Steroids21, 833–846 (1973)

    Google Scholar 

  3. D'Arcy, P.F., Griffin, J.P., Jenkins, J.S., Kirk, W.F., Peacock, A.W.C.: Sustained release formulation of prednisolone administered orally to man. J. Pharm. Sci.60, 1028–1033 (1971)

    Google Scholar 

  4. Dayton, P.G., Cucinell, S.A., Weiss, M., Perel, J.M.: Dose-dependence of drug plasma level decline in dogs. J. Pharmacol. Exp. Ther.158, 305–316 (1967)

    Google Scholar 

  5. DiSanto, A.R., DeSante, K.A.: Bioavailability and pharmacokinetics of prednisone in humans. J. Pharm. Sci.64, 109–112 (1975)

    Google Scholar 

  6. DiSanto, A.R., Wagner, J.G.: Potential erroneous assignment of non-linear data to the classical linear two-compartment open model. J. Pharm. Sci.61, 552–555 (1972)

    Google Scholar 

  7. English, J., Chakraborty, J., Marks, V.: A competitive protein binding method for plasma prednisolone assay. Ann. Clin. Biochem.11, 11–14 (1974)

    Google Scholar 

  8. Fell, P.J., Stevens, M.T.: Pharmacokinetics — uses and abuses. Europ. J. Clin. Pharmacol.8, 241–248 (1975)

    Google Scholar 

  9. Fotherby, K., James, F.: Metabolism of synthetic steroids. Advances in Steroid Biochemistry and Pharmacology,3, 124–165 (1972)

    Google Scholar 

  10. Gerber, N., Wagner, J.G.: Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of Michaelis-Menten equation. Res. Comm. Chem. Pathol. Pharmacol.3, 455 (1972)

    Google Scholar 

  11. Gibaldi, M., Perrier, D.: Pharmacokinetics. p. 45–60. New York: Marcel Dekker, Inc. 1975

    Google Scholar 

  12. Jähnchen, E., Levy, G.: Inhibition of phenylbutazone elimination by its metabolite oxyphenbutazone. Proc. Soc. Exp. Biol. Med.141, 963 (1972)

    Google Scholar 

  13. Jusko, W.J., Gretch, M.: Plasma and tissue protein binding of drugs in pharmacokinetics. Drug Metab. Rev.5, 43–140 (1976)

    Google Scholar 

  14. Jusko, W.J., Levy, G.: Pharmacokinetic evidence for saturable renal tubular reabsorption of riboflavin. J. Pharm. Sci.59, 765–772 (1970)

    Google Scholar 

  15. Kozower, M., Veatch, L., Kaplan, M.: Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects. J. Clin. Endocrinol. Metab.38, 407–412 (1974)

    Google Scholar 

  16. Kruger-Thiemer, E., Diller, W., Bunger, P.: Pharmacokinetic models regarding protein binding of drugs. Antimicrob. Agents Chemother.5, 183–191 (1965)

    Google Scholar 

  17. Levy, G.: Pharmacokinetics of salicylate elimination in man. J. Pharm. Sci.54, 959–967 (1965)

    Google Scholar 

  18. Lewis, G.P., Jusko, W.J., Burke, C.W., Graves, L.: Prednisone side-effects and serum protein levels. Lancet1971 II, 778–781

    Google Scholar 

  19. Meikle, A.W., Weed, J.A., Tyler, F.H.: Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunoassays. J. Clin. Endocrinol. Metab.41, 717–721 (1975)

    Google Scholar 

  20. Riegelman, S., Loo, J., Rowland, M.: Concept of a volume of distribution and possible errors in evaluation of this parameter. J. Pharm. Sci.57, 128–133 (1968)

    Google Scholar 

  21. Sandberg, D.H., Bacallao, C.Z., Cleveland, W.W.: Measurement of plasma prednisolone by a competitive protein binding assay. Biochem. Med.4, 383–390 (1970)

    Google Scholar 

  22. Swinscow, T.D.V.: Statistics at square one. XVII — Some non-parametric tests. Brit. Med. J.1976 III, 632–634

    Google Scholar 

  23. Sullivan, T.J., Sakmar, E., Albert, K.S., Blair, D.C., Wagner, J.G.: In vitro and in vivo availability of commercial prednisone tablets. J. Pharm. Sci.64, 1723–1725 (1975)

    Google Scholar 

  24. Sullivan, T.J., Stoll, R.G., Sakmar, E., Blair, D.C., Wagner, J.G.: In vitro and in vivo availability of some commercial prednisolone tablets. J. Pharmacokinet. Biopharm.2, 29–41 (1974)

    Google Scholar 

  25. Vermeulen, A.: The metabolism of 4-14C prednisolone. J. Endocrinol.18, 278–291 (1959)

    Google Scholar 

  26. Wilson, C.G., Ssendagire, R., May, C.S., Paterson, J.W.: Measurement of plasma prednisolone in man. Brit. J. clin. Pharmacol.2, 321–325 (1975)

    Google Scholar 

  27. Yates, F.E., Brennan, R.D.: Study in the mammalian glucocorticoid system by computer simulation. Technical report no. 320-3228, IBM Data Processing Division (1967)

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pickup, M.E., Lowe, J.R., Leatham, P.A. et al. Dose dependent pharmacokinetics of prednisolone. Eur J Clin Pharmacol 12, 213–219 (1977). https://doi.org/10.1007/BF00609864

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00609864

Key words

Navigation